The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...

The FDA approved brentuximab vedotin (Adcetris) in combination with lenalidomide (Revlimid) and rituximab for relapsed or ...

Efforts by the Trump administration to drastically cut federal investments in medical research are threatening to kneecap ...

The National Institutes of Health (NIH) is the largest single source of health care research funding in the U.S. The Trump ...

A top-ranking scientist at the National Institutes of Health, Dr. Lawrence Tabak, was forced to retire this week, multiple ...

On Monday, a federal judge temporarily averted disaster by halting the Trump administration’s plans to slash federal funding ...

Here’s what to know about Donald Trump’s NIH funding cuts. Americans are struggling with rising costs and high anxiety around ...

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

Michael Lauer, deputy director of the National Institutes of Health’s extramural research, will leave the agency at the end ...

After the National Institutes of Health issued an order Friday night that would dramatically reduce funding, professor ...

President Trump last Friday slashed billions from scientific research grants — effective Monday. Trump has taken issue with ...

The sudden policy change is that the NIH is to cap indirect cost recovery at 15 percent of the direct costs of a grant, ...